BSEC to probe share price hike of 2 pharma companies | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 13, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 13, 2025
BSEC to probe share price hike of 2 pharma companies

Stocks

TBS Report
16 July, 2020, 08:20 pm
Last modified: 16 July, 2020, 08:25 pm

Related News

  • Gold price goes up by Tk2,415 per bhori ahead of Eid
  • Tk2.52cr fines levied by BSEC for securities law breaches in May
  • Berger Paints rights share subscription starts 15 July
  • Berger Paints gets BSEC approval to issue rights shares
  • BSEC slashes BO account fee by Tk300

BSEC to probe share price hike of 2 pharma companies

The committee will submit the investigation report within the next 30 working days

TBS Report
16 July, 2020, 08:20 pm
Last modified: 16 July, 2020, 08:25 pm
BSEC to probe share price hike of 2 pharma companies

The Bangladesh Securities and Exchange Commission (BSEC) has formed an inquiry committee to investigate the unusual price hike of the shares of two pharmaceutical companies - Central Pharmaceuticals Ltd and Beacon Pharmaceuticals Ltd.

An official of the securities regulator told The Business Standard that the committee will investigate the unusual movements of both - share prices and volumes - of the listed companies.

"Shamsur Rahman, deputy director and Sultan Salauddin, assistant director of the BSEC are the two members of the committee," he added.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The committee will submit the investigation report within the next 30 working days.

Central Pharmaceuticals Ltd

In February this year, the company's share price suddenly jumped by 98 percent to Tk17 at the Dhaka Stock Exchange (DSE). However, in March, its share price fell by 41 percent.

In this regard, DSE had sent a notice to Central Pharma asking the reason for its unusual increase in share price. But the company replied that there was no price sensitive information for such an increase.

The Business Standard did a report on this unusual price hike.

The closing price of each Central Pharma share was Tk12.40 on Thursday at the DSE.

The company's board of directors jointly hold 25.89 percent shares which should be at least 30 percent as per law, according to industry sources.

The net profit of Central Pharmaceuticals Ltd dropped 64 percent to Tk5 crore in the last four years.

In the third quarter of the 2019-20 financial year, the company posted loss per share of Tk0.18.

In the 2018-19 financial year, Central Pharma paid only 1 percent cash dividend to its shareholders.

Beacon Pharmaceuticals Ltd

The share price of Beacon Pharmaceuticals Ltd increased by 271 percent to Tk74.20 in the last nine months.

The company also replied to the DSE notice saying that there was no price sensitive information for its share price hike.

In the third quarter of the last financial year, Beacon Pharma posted earnings per share of Tk0.55.

It paid 5 percent cash dividend to its shareholders in the 2018-19 financial year.

Economy / Top News

BSEC / Pharma / price hike / Share

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BNP Acting Chairperson Tarique Rahman and Chief Adviser  Muhammad Yunus meet at Dorchester Hotel in London, UK on 13 June 2025. Photo: CA Press Wing
    National polls possible in 2nd week of February, agree Yunus, Tarique in 'historic' London meeting
  • BNP Standing Committee member Amir Khosru Mahmud Chowdhury speaks at a joint press briefing after a high-level meeting of CA Prof Muhammad Yunus and BNP Acting Chairman Tarique Rahman in London on 13 June. Photo: CA's Press Wing
    BNP satisfied with Yunus-Tarique meeting outcome: Khasru
  • National Security Adviser and Chief Adviser’s High Representative Khalilur Rahman (2nd from left) speaks at a joint press briefing after a high-level meeting of CA Muhammad Yunus and BNP acting chairman Tarique Rahman in London on 13 June 2025. Photo: CA's Press Wing
    Election Commission will announce election date soon, hopes Khalilur

MOST VIEWED

  • Wreckage of a Boeing 787 Dreamliner showing part of its registration "VT-ANB" in Ahmedabad, India, June 12, 2025. REUTERS/Amit Dave
    Air India Dreamliner crashes into Ahmedabad college hostel, kills over 290
  • File Photo of Chief Adviser Muhammad Yunus: UNB
    Prof Yunus to receive Harmony Award from King Charles today
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Bangladesh mulls settlements with tycoons over offshore wealth: BB governor tells FT
  • Railway seeks Tk2,000cr foreign loans to revive coach assembly, modernise workshops
    Railway seeks Tk2,000cr foreign loans to revive coach assembly, modernise workshops
  • UK Prime Minister Keir Starmer, Chief Adviser Muhammad Yunus
    Disclosure of unconfirmed Yunus-Starmer meeting shows ‘diplomatic imprudence’: Analysts
  • Brother sues Latifur's daughter, widow over alleged forgery to seize control of Transcom
    Brother sues Latifur's daughter, widow over alleged forgery to seize control of Transcom

Related News

  • Gold price goes up by Tk2,415 per bhori ahead of Eid
  • Tk2.52cr fines levied by BSEC for securities law breaches in May
  • Berger Paints rights share subscription starts 15 July
  • Berger Paints gets BSEC approval to issue rights shares
  • BSEC slashes BO account fee by Tk300

Features

Photos: Collected

Kurtis that make a great office wear

51m | Mode
Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

1d | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

2d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

4d | Features

More Videos from TBS

'Historic' meeting between Yunus and Tarique underway in London

'Historic' meeting between Yunus and Tarique underway in London

2h | TBS Today
Iran warns Israel of severe retaliation

Iran warns Israel of severe retaliation

3h | TBS World
Global oil prices soar

Global oil prices soar

4h | TBS World
What did Iran say in response to the Israeli attack?

What did Iran say in response to the Israeli attack?

4h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net